Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-IDARAM and Intrathecal Immunochemotherapy in PCNSL
NCT02657785Phase 3Recruiting
- Start
- Sep 2010
- Primary completion
- Dec 2028
- Modality
- Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate in primary central nervous system lymphoma (PCNSL). Started Sep 2010; status: recruiting.
02
Drugs
rituximabidarubicindexamethasonecytarabinemethotrexate
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT02657785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02657785.